235 related articles for article (PubMed ID: 18308464)
21. Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in culture.
Miyashita K; Oyama T; Sakuta T; Tokuda M; Torii M
J Endod; 2012 Jun; 38(6):786-90. PubMed ID: 22595113
[TBL] [Abstract][Full Text] [Related]
22. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
23. Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner.
Paradisi A; Pasquariello N; Barcaroli D; Maccarrone M
J Biol Chem; 2008 Mar; 283(10):6005-12. PubMed ID: 18165231
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoids selectively enhance sweet taste.
Yoshida R; Ohkuri T; Jyotaki M; Yasuo T; Horio N; Yasumatsu K; Sanematsu K; Shigemura N; Yamamoto T; Margolskee RF; Ninomiya Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):935-9. PubMed ID: 20080779
[TBL] [Abstract][Full Text] [Related]
25. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
26. TRPV1 Activation by Anandamide via a Unique Lipid Pathway.
Muller C; Lynch DL; Hurst DP; Reggio PH
J Chem Inf Model; 2021 Dec; 61(12):5742-5746. PubMed ID: 34780173
[TBL] [Abstract][Full Text] [Related]
27. Anandamide induces necrosis in primary hepatic stellate cells.
Siegmund SV; Uchinami H; Osawa Y; Brenner DA; Schwabe RF
Hepatology; 2005 May; 41(5):1085-95. PubMed ID: 15841466
[TBL] [Abstract][Full Text] [Related]
28. The effect of anandamide on uterine nitric oxide synthase activity depends on the presence of the blastocyst.
Sordelli MS; Beltrame JS; Burdet J; Zotta E; Pardo R; Cella M; Franchi AM; Ribeiro ML
PLoS One; 2011 Apr; 6(4):e18368. PubMed ID: 21559512
[TBL] [Abstract][Full Text] [Related]
29. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.
Mestre L; Iñigo PM; Mecha M; Correa FG; Hernangómez-Herrero M; Loría F; Docagne F; Borrell J; Guaza C
J Neuroinflammation; 2011 Aug; 8():102. PubMed ID: 21851608
[TBL] [Abstract][Full Text] [Related]
30. The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor.
Williams MA; Smith SA; O'Brien DE; Mitchell JH; Garry MG
J Physiol; 2008 Feb; 586(3):835-45. PubMed ID: 18063665
[TBL] [Abstract][Full Text] [Related]
31. The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level.
Petrovszki Z; Kovacs G; Tömböly C; Benedek G; Horvath G
Anesth Analg; 2012 Jun; 114(6):1346-52. PubMed ID: 22451592
[TBL] [Abstract][Full Text] [Related]
32. Differential mechanisms mediating depressor and diuretic effects of anandamide.
Li J; Wang DH
J Hypertens; 2006 Nov; 24(11):2271-6. PubMed ID: 17053550
[TBL] [Abstract][Full Text] [Related]
33. Endocannabinoids, feeding and suckling--from our perspective.
Mechoulam R; Berry EM; Avraham Y; Di Marzo V; Fride E
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S24-8. PubMed ID: 16570101
[TBL] [Abstract][Full Text] [Related]
34. Anandamide centrally depresses the respiratory rhythm generator of neonatal mice.
Tree K; Caravagna C; Hilaire G; Peyronnet J; Cayetanot F
Neuroscience; 2010 Nov; 170(4):1098-109. PubMed ID: 20800658
[TBL] [Abstract][Full Text] [Related]
35. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
36. A putative 'pre-nervous' endocannabinoid system in early echinoderm development.
Buznikov GA; Nikitina LA; Bezuglov VV; Francisco ME; Boysen G; Obispo-Peak IN; Peterson RE; Weiss ER; Schuel H; Temple BR; Morrow AL; Lauder JM
Dev Neurosci; 2010 Mar; 32(1):1-18. PubMed ID: 19907129
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
Amorós I; Barana A; Caballero R; Gómez R; Osuna L; Lillo MP; Tamargo J; Delpón E
J Mol Cell Cardiol; 2010 Jan; 48(1):201-10. PubMed ID: 19616555
[TBL] [Abstract][Full Text] [Related]
38. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
40. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
Rubino T; Realini N; Castiglioni C; Guidali C; Viganó D; Marras E; Petrosino S; Perletti G; Maccarrone M; Di Marzo V; Parolaro D
Cereb Cortex; 2008 Jun; 18(6):1292-301. PubMed ID: 17921459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
